{"text": "rt AT_USER updating my list of anti-ctla4 assets. any obvious omissions? $adro $agen $mrk $xncr $bmy $azn #sitc17 URL"}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER updating my list of anti-ctla4 assets. any obvious omissions? $adro $agen $mrk $xncr $bmy $azn #sitc17 URL"}
{"text": "rt AT_USER AT_USER total costs must exceed $5 billion for $mrk, $pfe, $rhbby..."}
{"text": "bmo capital markets analysts give merck &amp; company, inc. $mrk a $70.00 price target URL"}
{"text": "$mrk: merck will not submit applications for regulatory approval for anacetrapib - investigational cholesteryl... URL"}
{"text": "bmo capital markets analysts give merck &amp; company, inc. $mrk a $70.00 price target URL"}
{"text": "rt AT_USER AT_USER total costs must exceed $5 billion for $mrk, $pfe, $rhbby..."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "merck bails on regulatory plans 4 its cetp-inhibitor, the last of a once-promising class of cholesterol drugs URL $mrk"}
{"text": "merck &amp; company, inc. $mrk given a $70.00 price target at bmo capital markets URL"}
{"text": "rt AT_USER merck $mrk won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' URL"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "merck &amp; company given $70.00 pt by bmo capital markets. buy rating. URL $mrk #mrk"}
{"text": "merck &amp; company given $70.00 pt by bmo capital markets. buy rating. URL $mrk #mrk"}
{"text": "merck &amp; company given $70.00 pt by bmo capital markets. buy rating. URL $mrk #mrk"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "after running expensive cvot and hitting pe $mrk cans anacetrapib URL"}
{"text": "#nih: experimental #ebola #vaccines elicit year-long immune response URL #pharma #biotech $mrk $gsk $nlnk #niaid"}
{"text": "scan results - macd bearish centerline cross today: $jnpr $fnf $bhge $regn $axta $ea $mrk $wm $qvca $cost ... URL"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "merck &amp; $mrk versus its peers financial comparison URL"}
{"text": "swing trade alert: scan results - fell below 50 dma today: $cuda $xper $ipg $kw $mrk\u00a1\u00ad URL via \u00a1\u00fa\u00a1\u00ad URL"}
{"text": "swing trade alert: scan results - fell below 50 dma today: $cuda $xper $ipg $kw $mrk\u00a1\u00ad URL via \u00a1\u00fa\u00a1\u00ad URL"}
{"text": "scan results - fell below 50 dma today: $cuda $xper $ipg $kw $mrk $rl $twnk $giii $amag $tgtx ... URL"}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "$ flows: buying on weakness: among stocks that were down wed, these had the largest net inflows of money $intc $c\u00a1\u00ad URL"}
{"text": "merck $mrk dumps cholesterol drug anacetrapib, shortly after shelving hepatitis c program; focus shifts back to cancer &amp; diabetes portfolio"}
{"text": "rt AT_USER merck $mrk won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' URL"}
{"text": "rt AT_USER merck $mrk won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' URL"}
{"text": "rt AT_USER the $mrk decision was a foregone conclusion the moment this sentence showed up in their press release back in july. URL"}
{"text": "rt AT_USER $mrk *merck &amp; co.: won't submit applications for anacetrapib"}
{"text": "merck $mrk won't seek regulatory approval for cholesterol-modifying drug anacetrapib, cites 'clinical profile' URL"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "the $mrk decision was a foregone conclusion the moment this sentence showed up in their press release back in july. URL"}
{"text": "as AT_USER speculated from #esccongress, $mrk now confirms anacetrapib is dead URL"}
{"text": "rt AT_USER AT_USER total costs must exceed $5 billion for $mrk, $pfe, $rhbby..."}
{"text": "merck bails on cholesterol med anacetrapib, no regulatory applications planned; shares down 1% after hours URL $mrk"}
{"text": "merck bails on cholesterol med anacetrapib, no regulatory applications planned; shares down 1% after hours URL $mrk"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "$mrk reminder: \"major coronary event occurred in 10.8% of patients in the anacetrapib group versus 11.8% of patients in the placebo group"}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER AT_USER total costs must exceed $5 billion for $mrk, $pfe, $rhbby..."}
{"text": "'going big': merck launches frontline phiii lung cancer study for keytruda/yervoy combo URL $mrk URL"}
{"text": "AT_USER total costs must exceed $5 billion for $mrk, $pfe, $rhbby..."}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "rt AT_USER $mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after\u00a1\u00ad"}
{"text": "$mrk says it won't seek approval for cholesterol drug anacetrapib, as clinical profile doesn't support it. $mrk -0.8% after hrs"}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "rt AT_USER $mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "$mrk will not seek approval of anacetrapib. cetp inhibitors are finally, really, truly dead."}
{"text": "$mrk *merck &amp; co.: won't submit applications for anacetrapib"}
{"text": "this drugmaker hit a four-month high on collaboration with dow's merck $mrk $sgen URL"}
{"text": "$mrk could drop roughly $750m for kalvista's diabetic macular edema drug URL $kalv"}
{"text": "phocas financial has lowered merck &amp; co $mrk holding by $681,280 as share value declined ..."}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "AT_USER $mrk likely suitor for $opgn"}
{"text": "$mrk risk reversal trades 4,350 times URL"}
{"text": "rt AT_USER hurricane-related damage could cause shortages of 40 drugs - fda URL $bmy $mrk $pfe $agn"}
{"text": "hurricane-related damage could cause shortages of 40 drugs - fda URL $bmy $mrk $pfe $agn"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "sold/took profits on $on, $mrk, and $lpla.  added $cl."}
{"text": "hurricane-related damage could cause shortages of 40 drugs - fda URL $bmy $mrk $pfe $agn"}
{"text": "hurricane-related damage could cause shortages of 40 drugs - fda URL $bmy $mrk $pfe $agn"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "estabrook capital management decreased merck &amp; company $mrk position by $300.26 million ..."}
{"text": "11:40 et volume leader #93 - mrk 2,704,065 merck &amp; company $mrk 63.62 -0.84 -1.30% high today of 64.34 day low URL"}
{"text": "#partners at URL hold #degrees from #elite #private #universities $pg $cvx $mrk $cmcsa $txn #fridayfeeling"}
{"text": "#partners at URL hold #degrees from #elite #private #universities $pg $cvx $mrk $cmcsa $txn #fridayfeeling"}
{"text": "#partners at URL hold #degrees from #elite #private #universities $pg $cvx $mrk $cmcsa $txn #fridayfeeling"}
{"text": "#partners at URL hold #degrees from #elite #private #universities $pg $cvx $mrk $cmcsa $txn #fridayfeeling"}
{"text": "URL $kalv $lly $mrk $nvs $once $pfe $rhhby"}
{"text": "$mrk invests in diabetes through kalvista deal URL $kalv"}
{"text": "$mrk invests in diabetes through kalvista deal URL $kalv"}
{"text": "mrk top news - oct 11th, 2017 $mrk URL"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "4,350 of $62.50 $mrk 2018-01-19 put options traded for $696,000.00 (bought on the ask for $1.60) $spx $iwm $qqq\u00a1\u00ad URL"}
{"text": "$mrk #gardasil 9 offers at least 6 years of #cancer protection, data show #hpv #infectiousdisease $mrk URL"}
{"text": "$mrk pays $760m to buy into $kalv drug for #diabetic #eyedisease #biotech #diabetes #dme #pharma URL"}
{"text": "rt AT_USER AT_USER $kalv btig initiated with a buy and $18 price target recently.  wondering if other analysts might initiate cover\u00a1\u00ad"}
{"text": "$kalv $mrk paid $8.50 - may be a good entry there for swing trade."}
{"text": "zacks investment research lowers merck &amp; company, inc. $mrk to sell URL"}
{"text": "merck &amp; company downgraded by zacks investment research to sell. URL $mrk #mrk"}
{"text": "merck &amp; company downgraded by zacks investment research to sell. URL $mrk #mrk"}
{"text": "investors buy shares of merck &amp; company, inc. $mrk on weakness URL"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "rt AT_USER 25 largest pharma/biotech pe not expensive going forward here $ibb $btk $nbi $mrk $jnj $gild $celg URL"}
{"text": "investors buy shares of merck &amp; company, inc. $mrk on weakness URL"}
{"text": "rt AT_USER decoding cancer: the four trends that are turning precision medicine into a reality URL $loxo $mrk $fm\u00a1\u00ad"}
{"text": "merck &amp; company, inc. $mrk shares sold by grandfield &amp; dodd llc URL"}
